김태환 교수 연구실
article|
인용수 0
·2025
PD37-09 THE FIRST REPORT OF DISEASE-FREE SURVIVAL ANALYSES FROM THE NIAGARA TRIAL OF PERIOPERATIVE DURVALUMAB PLUS NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER
Joshua J. Meeks, Michiel S. van der Heijden, Thomas Powles, Matthew D. Galsky, Hikmat Al‐Ahmadie, Hiroyuki Nishiyama, Alexandra Drakaki, Toan Quang Vu, Lorenzo Antonuzzo, Paweł Wiechno, Vagif Atduev, Ariel Galapo Kann, Tae‐Hwan Kim, Cristina Suárez, Albert Font Pous, Chao-Hsiang Chang, Wenjing Xin, Svetlana Ho, Małgorzata Gula, James W.F. Catto
IF 6.8The Journal of Urology
키워드
MedicineDurvalumabBladder cancerChemotherapyPerioperativeCystectomyDiseaseCancerOncologySurgery